Biological Activity
GLYX-13 is a selective weak partial agonist of the glycine site of the NMDA receptor which is under development by Naurex as adjunctive therapy for treatment-resistant depression.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 24.19 mL | 120.93 mL | 241.86 mL |
0.5 mM | 4.84 mL | 24.19 mL | 48.37 mL |
1 mM | 2.42 mL | 12.09 mL | 24.19 mL |
5 mM | 0.48 mL | 2.42 mL | 4.84 mL |
*The above data is based on the productmolecular weight 413.47. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Catalog Num | A13576 |
---|---|
Actions | Modulator |
M. Wt | 413.47 |
Formula | C18H31N5O6 |
Solubility | DMSO |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 117928-94-6 |
Synonyms | GLYX 13, GLYX13 |
SMILES | C[[email protected]]([[email protected]@H](C(=O)N1CCC[[email protected]]1C(=O)N2CCC[[email protected]]2C(=O)N[[email protected]@H]([[email protected]@H](C)O)C(=O)N)N)O |
Datasheet
Product Tags
Product Questions
Product Questions
No Questions
Keywords:buy GLYX-13 (Rapastinel) | GLYX-13 (Rapastinel) Supplier | purchase | cost | manufacturer | order | distributor | buy 117928-94-6| 117928-94-6 Supplier | purchase 117928-94-6 | 117928-94-6 cost | 117928-94-6 manufacturer | order 117928-94-6 | 117928-94-6 distributor